VIVO
Weill Cornell Medical College
Index
Log in
Search form
Home
People
Organizations
Research
Support
Ceftazidime-Avibactam versus Meropenem-Vaborbactam for the treatment of bloodstream infections and/or pneumonia due to carbapenem-resistant Enterobacterales (CAMEL)
Grant
Overview
date/time interval
April 9, 2024 -
awarded by
Melinta Therapeutics, Inc.
administered by
Medicine-Infectious Diseases
sponsor award ID
UP 253751-01
Affiliation
contributor
Satlin, Michael
Principal Investigator (Subaward)
2024 - 2026